Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the “Warburg Effect”, i.e., elevated glycolysis in the presence of oxygen

  title={Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the “Warburg Effect”, i.e., elevated glycolysis in the presence of oxygen},
  author={Peter L. Pedersen},
  journal={Journal of Bioenergetics and Biomembranes},
  • P. Pedersen
  • Published 19 September 2007
  • Biology
  • Journal of Bioenergetics and Biomembranes
As a new faculty member at The Johns Hopkins University, School of Medicine, the author began research on cancer in 1969 because this frequently fatal disease touched many whom he knew. He was intrigued with its viscous nature, the failure of all who studied it to find a cure, and also fascinated by the pioneering work of Otto Warburg, a biochemical legend and Nobel laureate. Warburg who died 1 year later in 1970 had shown in the 1920s that the most striking biochemical phenotype of cancers is… 

Oxidative Phosphorylation and Cancer: The Ongoing Warburg Hypothesis

It is suggested that reactivating mitochondrial metabolism by pharmacologic or dietary measures and/or tackling the deviant glycolysis in cancer cells may efficiently suppress malignant growth.

The Warburg effect: insights from the past decade.

Discovery of a novel glucose metabolism in cancer: The role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt

It is discovered that 18F-fluorodeoxyglucose preferentially accumulates within endoplasmic reticulum by exploiting the catalytic function of hexose-6-phosphate-dehydrogenase, which can improve clinical cancer diagnosis and might represent potential target for therapy.

Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication.

Understanding metabolic flexibility by lactate shuttles offers new perspectives to develop treatments that target the hypoxic tumor microenvironment and overcome the limitations of glycolytic inhibitors.

Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype

Accumulating data unequivocally demonstrate that aerobic glycolysis implicates myriad of molecular and functional processes to support cancer progression.

Manipulation of glycolysis in malignant tumors: fantasy or therapy?

An emerging field of research is the manipulation of tumor cell metabolism for therapeutic purposes; respective studies include approaches of glycolytic inhibition or forcing mitochondrial respiration, respectively, based on biochemical and molecular principles.

Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis.

The concept of metabolic remodeling and signaling in tumors, specifically the various metabolites that participate in the regulation of gene expression in cancer cells are discussed, and several mitochondrial DNA mutations were reported in tumors.



Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria

3-bromopyruvate is shown recently to eradicate advanced stage, PET positive hepatocellular carcinomas in an animal model without apparent harm to the animals and is currently being investigated in several laboratories in a strategy to develop novel therapies that may turn the tide on the continuing struggle to find effective cures for cancer.

Tumor metabolism: new opportunities for cancer therapy

  • I. MéridaA. Ávila-Flores
  • Biology
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
  • 2006
A new scenario is emerging, in which bioenergetics would contribute to and sustain malignant transformation, and tumor reliance on glycolysis can be exploited in the search for novel, more potent therapeutic approaches to cancer treatment.

Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP.

Results provide the first direct demonstration that the exceptionally high level of hexokinase bound to mitochondria of highly glycolytic tumor cells has preferred access to mitochondrially generated ATP, a finding that may have rather profound metabolic significance for such tumors.

Mitochondria and cancer: Warburg addressed.

  • D. Wallace
  • Biology
    Cold Spring Harbor symposia on quantitative biology
  • 2005
It now appears that cancer cells generate excessive lactate in the presence of oxygen is the product of two factors: a return to the more glycolytic metabolism of the embryo and alterations in oxidative phosphorylation to increase mitochondrial reactive oxygen species (ROS) production.

Glucose Catabolism in Cancer Cells

These novel studies identify and characterize a marked glucose-modulated activation response of the type II hexokinase gene to hypoxic conditions within highly glycolytic hepatoma cells, a property that may help assure that such cells exhibit a growth and survival advantage over their parental cells of origin.

Oxidative metabolism in cancer growth

  • M. Ristow
  • Biology
    Current opinion in clinical nutrition and metabolic care
  • 2006
This review summarizes published evidence on the essential interaction of tumor growth and mitochondrial metabolism, implicating novel approaches for the prevention and treatment of malignant disease.

Mitochondrial Hexokinases: Guardians of the Mitochondria

It is speculated that, somewhere in the course of evolution, themetabolic regulatory function of Akt evolved into an adaptive sensing system involving mtHK thatensures mitochondrial homeostasis, thereby coupling metabolism to cell survival.

Glucose Metabolism in Cancer

Novel observations indicate that one of the initial events in activating the HKII gene during either transformation or tumor progression may reside at the epigenetic level.

The molecular correlation concept of neoplasia.